Identifying markers for personalized treatment in chronic lymphocytic leukemia
Predictive markers for personalized therapy in chronic lymphocytic leukemia
This study is looking for ways to find special markers in people with chronic lymphocytic leukemia (CLL) that can help doctors create more personalized and effective treatments just for you.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11058432 on NIH RePORTER |
What this research studies
This research focuses on developing predictive markers that can help tailor personalized therapies for patients with chronic lymphocytic leukemia (CLL). By identifying specific biomarkers, the goal is to enhance treatment effectiveness and improve patient outcomes. The research involves advanced techniques in biomarker assay development and biostatistics, ensuring that the findings can be translated into clinical practice. Patients may benefit from more targeted therapies that are better suited to their individual disease profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic lymphocytic leukemia, particularly those with specific genetic markers.
Not a fit: Patients with other types of leukemia or those who do not have chronic lymphocytic leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with chronic lymphocytic leukemia.
How similar studies have performed: Previous research has shown promise in developing personalized therapies based on biomarkers in similar conditions, indicating a potential for success in this approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Soumerai, Jacob — Massachusetts General Hospital
- Study coordinator: Soumerai, Jacob
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.